However, clinical considerations exist that warrant careful evaluation
Important safety considerations: Seek urgent same-day medical assessment via NHS 111 or A&E for severe abdominal pain (potential pancreatitis) and stop taking the medication pending review Report persistent nausea, vomiting, or signs of dehydration Be aware of increased hypoglycaemia risk if taking insulin or sulfonylureas (dose adjustments may be needed) Attend regular monitoring appointments for kidney function, diabetic retinopathy, and other parameters Discuss contraception if you are of childbearing potential, as GLP-1 receptor agonists are generally not recommended during pregnancy or breastfeeding [11] Report any suspected side effects via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk) Specific administration requirements vary by product
This ensures the medication is appropriate for your medical history and that you receive proper dosing and follow-up care
Is the $499 Ozempic and Wegovy offer available in every state
Pieninck president and CEO effective October 1, 2025, succeeding Pat Geraghty, who retired after 14 years in which the enterprise grew from an $8 billion health insurer into a $32 billion Fortune 500 company
Jan;12(1):37-51